deltatrials
Completed PHASE3 NCT00151515

A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss

A Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of 5 Percent Minoxidil Foam in the Treatment of Androgenetic Alopecia in Males

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide

Conditions Androgenetic Alopecia
Interventions minoxidil
Updated 6 times since 2017 Last updated: Sep 28, 2016 Started: Oct 31, 2003 Primary completion: Jul 31, 2004 Completion: Jul 31, 2004

This PHASE3 trial investigates Androgenetic Alopecia and is currently completed. Johnson & Johnson Consumer and Personal Products Worldwide leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Johnson & Johnson Consumer and Personal Products Worldwide
Data source: Johnson & Johnson Consumer and Personal Products Worldwide

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austin, United States, Cincinnati, United States, Cleveland, United States, Dallas, United States, Denver, United States, Durham, United States, Fridley, United States, Hershey, United States, La Jolla, United States, Minneapolis, United States and 5 more location s